Total investments

12

Average round size

22M

Portfolio companies

7

Rounds per year

0.57

Follow on index

0.42

Exits

5

Stages of investment
Private EquityEarly Stage VentureLate Stage Venture
Areas of investment
BiotechnologySoftwareHealth CareEnterprise SoftwareDeliveryBusiness IntelligenceMedical DeviceMedicalContentTelecommunications

Summary

Viola Partners appeared to be the VC, which was created in 2000. The venture was found in Asia in Israel. The leading representative office of defined VC is situated in the Herzliya.

The current fund was established by Aharon Dovrat, Shlomo Dovrat. Besides them, we counted 1 critical employee of this fund in our database.

Among the various public portfolio startups of the fund, we may underline Clicktale, Lumenis, AngioSlide For fund there is a match between the country of its foundation and the country of its the most frequent investments - Israel. Among the most popular fund investment industries, there are Data Center, E-Commerce. The fund has specific favorite in a number of founders of portfolio startups. Besides, a startup requires to be at the age of 11-15 years to receive the investment from the fund.

The typical case for the fund is to invest in rounds with 3-4 participants. Despite the Viola Partners, startups are often financed by XT Investments, Viola Growth, Viola Credit. The meaningful sponsors for the fund in investment in the same round are XT Investments, Viola Growth, Agate Medical Investments. In the next rounds fund is usually obtained by Viola Credit, XT Investments, Agate Medical Investments.

Deals in the range of 10 - 50 millions dollars are the general things for fund. Comparing to the other companies, this Viola Partners performs on 13 percentage points more the average number of lead investments. The important activity for fund was in 2006. When the investment is from Viola Partners the average startup value is 100-500 millions dollars. The higher amount of exits for fund were in 2006. The fund is generally included in less than 2 deals every year.

Show more

Investments analytics

Analytics

Total investments
12
Lead investments
0
Exits
5
Rounds per year
0.57
Follow on index
0.42
Investments by industry
  • Medical (6)
  • Biotechnology (6)
  • Health Care (6)
  • Medical Device (5)
  • Enterprise Software (3)
  • Show 16 more
Investments by region
  • Israel (4)
  • Germany (2)
  • United States (5)
  • United Kingdom (1)
Peak activity year
2006

Discover reliable insights

Leverage validated data, identify key contacts and secure funding opportunities for your business.

Quantitative data

Avg. startup age at the time of investment
34
Avg. valuation at time of investment
114M
Group Appearance index
0.83
Avg. company exit year
25
Avg. multiplicator
1.59

Need more data?

Get access to full data about investors, including their team, contact information, and historic data.

Latest deals

Company name Deal date Industry Deal stage Deal size Location
AngioSlide 01 Dec 2006 Biotechnology, Health Care, Medical Device, Medical Early Stage Venture 4M United States, Colorado

Similar funds

By same location

By same geo focus

By doing lead investments

How we get our data

At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).

Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.